{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:05:15Z","timestamp":1787011515337,"version":"build-2736575974"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","award":["2451-0-0"],"award-info":[{"award-number":["2451-0-0"]}],"id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["DP21014"],"award-info":[{"award-number":["DP21014"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["KI20130"],"award-info":[{"award-number":["KI20130"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["LW0005"],"award-info":[{"award-number":["LW0005"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJCLS 05R\/2017"],"award-info":[{"award-number":["DJCLS 05R\/2017"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70114948"],"award-info":[{"award-number":["70114948"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC2180-390900677"],"award-info":[{"award-number":["EXC2180-390900677"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA4608\/1-2"],"award-info":[{"award-number":["WA4608\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2016.177.3"],"award-info":[{"award-number":["2016.177.3"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.smim.2023.101725","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:35:45Z","timestamp":1674639345000},"page":"101725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Viral T-cell epitopes \u2013 Identification, characterization and clinical application"],"prefix":"10.1016","volume":"66","author":[{"given":"Sarah M.","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Nelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane S.","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib1","first-page":"21","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proceedings"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","article-title":"The immune system. First of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. Second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"issue":"36","key":"10.1016\/j.smim.2023.101725_bib5","doi-asserted-by":"crossref","first-page":"eabj5365","DOI":"10.1126\/sciadv.abj5365","article-title":"Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination","volume":"7","author":"Caniels","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7030074","article-title":"Impact of HIV-1 diversity on its sensitivity to neutralization","volume":"7","author":"Stefic","year":"2019","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib7","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/s41375-021-01270-w","article-title":"COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia","volume":"35","author":"Roeker","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","article-title":"Seroconversion rates following COVID-19 vaccination among patients with cancer","volume":"39","author":"Thakkar","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00129785-200404050-00002","article-title":"Human genetics and responses to influenza vaccination: clinical implications","volume":"4","author":"Lambkin","year":"2004","journal-title":"Am. J. Pharmacogenom."},{"issue":"10","key":"10.1016\/j.smim.2023.101725_bib10","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.4049\/jimmunol.164.10.5005","article-title":"Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses","volume":"164","author":"Molano","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/IAI.00566-07","article-title":"Class II-restricted protective immunity induced by malaria sporozoites","volume":"76","author":"Oliveira","year":"2008","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.smim.2023.101725_bib12","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2008.04.018","article-title":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities","volume":"28","author":"Sette","year":"2008","journal-title":"Immunity"},{"issue":"5617","key":"10.1016\/j.smim.2023.101725_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm0202-166","article-title":"IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages","volume":"8","author":"Carvalho","year":"2002","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.179.2.1113","article-title":"The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection","volume":"179","author":"Kemball","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.173.2.969","article-title":"Fully functional memory CD8 T cells in the absence of CD4 T cells","volume":"173","author":"Marzo","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2008.03.007","article-title":"Cytotoxic human CD4(+) T cells","volume":"20","author":"van de Berg","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"19","key":"10.1016\/j.smim.2023.101725_bib19","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1128\/JVI.01159-08","article-title":"Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords","volume":"82","author":"Johnson","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2353\/ajpath.2008.080142","article-title":"Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis","volume":"173","author":"Elyaman","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.172.5.1353","article-title":"CD4+ cytolytic T cell clone confers protection against murine malaria","volume":"172","author":"Tsuji","year":"1990","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2023.101725_bib23","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.05577-11","article-title":"HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome","volume":"86","author":"Ranasinghe","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101725_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","article-title":"The CD8 T cell response to respiratory virus infections","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2023.101725_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0008-8749(79)90178-3","article-title":"Role of T-cell function in recovery from murine influenza infection","volume":"43","author":"Yap","year":"1979","journal-title":"Cell Immunol."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41423-022-00838-5","article-title":"T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant","volume":"19","author":"Choi","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","article-title":"Unbiased screens show CD8(+) T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein","volume":"53","author":"Ferretti","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib32","first-page":"146","article-title":"Cross reactive T cells hold up against Omicron","volume":"22","author":"Flemming","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","volume":"6","author":"Geers","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2701.203611","article-title":"Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France","volume":"27","author":"Gallais","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"issue":"D1","key":"10.1016\/j.smim.2023.101725_bib37","first-page":"D948","article-title":"IPD-IMGT\/HLA database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108454","article-title":"The human leukocyte antigen class II immunopeptidome of the SARS-CoV-2 spike glycoprotein","volume":"33","author":"Knierman","year":"2020","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib39","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.178.7.4455","article-title":"T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection","volume":"178","author":"Khan","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"D1","key":"10.1016\/j.smim.2023.101725_bib41","doi-asserted-by":"crossref","first-page":"D10","DOI":"10.1093\/nar\/gkaa892","article-title":"Database resources of the National Center for Biotechnology Information","volume":"49","author":"Sayers","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.smim.2023.101725_bib42","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"UniProt","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6324","key":"10.1016\/j.smim.2023.101725_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.smim.2023.101725_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00189978","article-title":"Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing","volume":"40","author":"Maier","year":"1994","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.153.3.1141","article-title":"Analysis of allele-specific contact sites of natural HLA-DR17 ligands","volume":"153","author":"Malcherek","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700438","article-title":"Broad and efficient activation of memory CD4(+) T cells by novel HAdV- and HCMV-derived peptide pools","volume":"12","author":"H\u00f6ttler","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/scitranslmed.abf7517","article-title":"T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals","volume":"13","author":"Bilich","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"7894","key":"10.1016\/j.smim.2023.101725_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","article-title":"A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity","volume":"601","author":"Heitmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101725_bib51","article-title":"Phase I\/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency","author":"Walz","year":"2022","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s40425-019-0796-5","article-title":"A new synthetic toll-like receptor 1\/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer","volume":"7","author":"Rammensee","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib53","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC Class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12879-020-4876-4","article-title":"Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort","volume":"20","author":"Bugembe","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2023.101725_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1084\/jem.20191164","article-title":"Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models","volume":"217","author":"L\u00fcbke","year":"2020","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.smim.2023.101725_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.smim.2023.101725_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinforma."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10989-021-10345-2","article-title":"VirVACPRED: a web server for prediction of protective viral antigens","volume":"28","author":"Herrera-Bravo","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.smim.2023.101725_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705974","article-title":"Immunopeptidomics-guided warehouse design for peptide-based immunotherapy in chronic lymphocytic leukemia","volume":"12","author":"Nelde","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712488","article-title":"T cell epitope prediction and its application to immunotherapy","volume":"12","author":"Schaap-Johansen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-immunol-082119-124838","article-title":"T cell epitope predictions","volume":"38","author":"Peters","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac141","article-title":"Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens","volume":"23","author":"Buckley","year":"2022","journal-title":"Brief. Bioinforma."},{"key":"10.1016\/j.smim.2023.101725_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.addr.2021.01.007","article-title":"In silico T cell epitope identification for SARS-CoV-2: progress and perspectives","volume":"171","author":"Sohail","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"D1","key":"10.1016\/j.smim.2023.101725_bib64","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.smim.2023.101725_bib65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-9450-2_10","article-title":"Purification and identification of naturally presented MHC Class I and II ligands","volume":"1988","author":"Nelde","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib67","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.4049\/jimmunol.181.9.6371","article-title":"Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling","volume":"181","author":"Meyer","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib68","first-page":"474","article-title":"Identification of naturally processed mumps virus epitopes by mass spectrometry: confirmation of multiple CD8+ T-Cell responses in mumps patients","volume":"221","author":"de Wit","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2023.101725_bib69","article-title":"MHC Class I presented T cell epitopes as potential antigens for therapeutic vaccine against HBV chronic infection","volume":"2014","author":"Comber","year":"2014","journal-title":"Hepat. Res. Treat."},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CJI.0000000000000087","article-title":"Identification of a novel immunodominant HLA-B*07: 02-restricted adenoviral peptide epitope and its potential in adoptive transfer immunotherapy","volume":"38","author":"Gunther","year":"2015","journal-title":"J. Immunother."},{"issue":"17\u201318","key":"10.1016\/j.smim.2023.101725_bib71","article-title":"Direct identification of HLA-presented CD8 T cell epitopes from transmitted founder HIV-1 variants","volume":"21","author":"Hare","year":"2021","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/eji.201545890","article-title":"Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells","volume":"46","author":"Ternette","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"22","key":"10.1016\/j.smim.2023.101725_bib73","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1128\/JVI.01914-14","article-title":"Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells","volume":"88","author":"Yaciuk","year":"2014","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/jir814","article-title":"Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response","volume":"205","author":"Testa","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib75","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1073\/pnas.0711874105","article-title":"Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes","volume":"105","author":"McMurtrey","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009894","article-title":"Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands","volume":"18","author":"Nicholas","year":"2022","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.smim.2023.101725_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048484","article-title":"MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response","volume":"7","author":"Testa","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.0811271106","article-title":"HLA class I molecules consistently present internal influenza epitopes","volume":"106","author":"Wahl","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib79","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/s41467-019-10661-8","article-title":"Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.smim.2023.101725_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109305","article-title":"Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics","volume":"35","author":"Nagler","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2023.101725_bib81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.2111815118","article-title":"Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs","volume":"118","author":"Pan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.smim.2023.101725_bib82","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","article-title":"Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs","volume":"184","author":"Weingarten-Gabbay","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib83","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1073\/pnas.1815239116","article-title":"Most viral peptides displayed by class I MHC on infected cells are immunogenic","volume":"116","author":"Croft","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003129","article-title":"Kinetics of antigen expression and epitope presentation during virus infection","volume":"9","author":"Croft","year":"2013","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib85","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.06084-11","article-title":"An overview of the vaccinia virus infectome: a survey of the proteins of the poxvirus-infected cell","volume":"86","author":"Chou","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101725_bib86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.smim.2023.101725_bib87","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Proteom. Clin. Appl."},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib88","doi-asserted-by":"crossref","first-page":"C98","DOI":"10.12968\/hmed.2016.77.7.C98","article-title":"Enzyme-linked immunosorbent assay (ELISA): the basics","volume":"77","author":"Shah","year":"2016","journal-title":"Br. J. Hosp. Med."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib89","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1046-2023(02)00348-1","article-title":"T-cell epitope mapping using the ELISPOT approach","volume":"29","author":"Anthony","year":"2003","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12865-016-0182-8","article-title":"Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells","volume":"17","author":"Surenaud","year":"2016","journal-title":"BMC Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4939-7346-0_9","article-title":"Multiparameter intracellular cytokine staining","volume":"1678","author":"Lovelace","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib92","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/cyto.a.23724","article-title":"Comprehensive phenotyping of T cells using flow cytometry","volume":"95","author":"Mousset","year":"2019","journal-title":"Cytometry A"},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib93","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cyto.a.24317","article-title":"A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19","volume":"99","author":"Geanon","year":"2021","journal-title":"Cytometry A"},{"issue":"1\u20132","key":"10.1016\/j.smim.2023.101725_bib94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jim.2003.09.001","article-title":"Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells","volume":"283","author":"Karlsson","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1360","article-title":"Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate","volume":"11","author":"De Rosa","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib96","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/JVI.02572-12","article-title":"Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity","volume":"87","author":"Yagita","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101725_bib97","first-page":"59","article-title":"51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells","volume":"37","author":"McCoy","year":"1973","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib99","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.gendis.2021.05.006","article-title":"Identification of cross-reactive CD8(+) T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants","volume":"9","author":"Hu","year":"2022","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.immuni.2016.09.015","article-title":"Antiviral CD8(+) T Cells restricted by human leukocyte antigen Class II exist during natural HIV infection and exhibit clonal expansion","volume":"45","author":"Ranasinghe","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110214","article-title":"Recruitment of highly cytotoxic CD8(+) T cell receptors in mild SARS-CoV-2 infection","volume":"38","author":"Wagner","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib102","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2020.323","article-title":"Real time visualization of cancer cell death, survival and proliferation using fluorochrome-transfected cells in an IncuCyte((R)) imaging system","volume":"7","author":"Lanigan","year":"2020","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.smim.2023.101725_bib103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jim.2014.01.012","article-title":"An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells","volume":"405","author":"Peper","year":"2014","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib104","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1158\/2326-6066.CIR-18-0129","article-title":"The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity","volume":"6","author":"Danilova","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.smim.2023.101725_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.735584","article-title":"A framework to identify antigen-expanded T cell receptor clusters within complex repertoires","volume":"12","author":"Ceglia","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib106","article-title":"Characterization and monitoring of antigen-responsive T cell clones using T cell receptor gene expression analysis","volume":"11","author":"Pollastro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib107","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fimmu.2020.00591","article-title":"A T cell receptor sequencing-based assay identifies cross-reactive recall CD8(+) T cell clonotypes against autologous HIV-1 epitope variants","volume":"11","author":"Chan","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib108","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/tri.12318","article-title":"Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm","volume":"27","author":"Lucia","year":"2014","journal-title":"Transpl. Int."},{"key":"10.1016\/j.smim.2023.101725_bib109","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-CT258","volume":"82","author":"Tandler","year":"2022","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjh.18149","article-title":"Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination","volume":"197","author":"Riise","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"20","key":"10.1016\/j.smim.2023.101725_bib111","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.smim.2023.101725_bib112","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14653241003587645","article-title":"Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response","volume":"12","author":"Feuchtinger","year":"2010","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.smim.2023.101725_bib114","first-page":"9","article-title":"Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients","author":"Sommerer","year":"2021","journal-title":"Vaccines"},{"issue":"31","key":"10.1016\/j.smim.2023.101725_bib115","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf Virus-Specific T cells to treat BK Virus, human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib116","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/TP.0000000000000272","article-title":"Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells","volume":"99","author":"Van Craenenbroeck","year":"2015","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib117","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2352-3026(15)00246-X","article-title":"Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial","volume":"3","author":"Nakamura","year":"2016","journal-title":"Lancet Haematol."},{"issue":"31","key":"10.1016\/j.smim.2023.101725_bib118","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.vaccine.2005.03.010","article-title":"Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization","volume":"23","author":"Kran","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib119","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/00365548.2011.653581","article-title":"Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years","volume":"44","author":"Lind","year":"2012","journal-title":"Scand. J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.smim.2023.101725_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011995","article-title":"Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity","volume":"5","author":"Graham","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2023.101725_bib121","first-page":"138","article-title":"A Phase II randomized, double-blind, placebo-controlled, multicenter trial to evaluate the efficacy of cmvpepvax for preventing CMV reactivation\/disease after matched related\/unrelated donor hematopoietic cell transplant","author":"Nakamura","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.smim.2023.101725_bib122","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1089\/aid.2013.0076","article-title":"Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau","volume":"29","author":"Roman","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib123","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vaccine.2008.10.051","article-title":"Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial","volume":"27","author":"Spearman","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib124","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Levy","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101725_bib125","doi-asserted-by":"crossref","first-page":"2100189","DOI":"10.1080\/21645515.2022.2100189","article-title":"A personal COVID-19 dendritic cell vaccine made at point-of-care: feasibility, safety, and antigen-specific cellular immune responses","author":"Nistor","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.smim.2023.101725_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008011","article-title":"Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination","volume":"15","author":"Surenaud","year":"2019","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib127","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32834f33e8","article-title":"mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients","volume":"26","author":"Van Gulck","year":"2012","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib128","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ymthe.2018.04.009","article-title":"HIV-specific T cells generated from Naive T cells suppress HIV in vitro and recognize wide epitope breadths","volume":"26","author":"Patel","year":"2018","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.smim.2023.101725_bib129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiv022","article-title":"Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir","volume":"212","author":"Sung","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.smim.2023.101725_bib130","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.ymthe.2018.08.015","article-title":"HIV-specific, ex vivo expanded T cell therapy: feasibility, safety, and efficacy in ART-suppressed HIV-infected individuals","volume":"26","author":"Sung","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.smim.2023.101725_bib131","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.06.027","article-title":"Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient","volume":"65","author":"L\u00f6ffler","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.smim.2023.101725_bib132","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1053\/j.gastro.2008.02.058","article-title":"Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41","volume":"134","author":"Klade","year":"2008","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.smim.2023.101725_bib133","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00262-018-2158-4","article-title":"Personalized cancer vaccines: adjuvants are important, too","volume":"67","author":"Gouttefangeas","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.smim.2023.101725_bib134","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13189","article-title":"The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients","volume":"21","author":"Gardiner","year":"2019","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines","volume":"1","author":"Aucouturier","year":"2002","journal-title":"Expert Rev. Vaccin."},{"issue":"3","key":"10.1016\/j.smim.2023.101725_bib136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00126839-200809030-00001","article-title":"A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases","volume":"9","author":"Gupta","year":"2008","journal-title":"Drugs RD"},{"issue":"1","key":"10.1016\/j.smim.2023.101725_bib137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.seminhematol.2005.09.005","article-title":"Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion","volume":"43","author":"Porter","year":"2006","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.smim.2023.101725_bib138","article-title":"FDA approval: Pfizer-BioNTech COVID-19 vaccines comirnaty and Pfizer-BioNTech COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine","author":"FDA","year":"2021","journal-title":"Bivalent"},{"issue":"17","key":"10.1016\/j.smim.2023.101725_bib139","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.smim.2023.101725_bib140","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery","volume":"357","author":"Cao","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532323000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532323000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:23:55Z","timestamp":1760916235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532323000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":140,"alternative-id":["S1044532323000167"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2023.101725","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral T-cell epitopes \u2013 Identification, characterization and clinical application","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2023.101725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101725"}}